Results of a prospective observational study of imiglucerase biosimilar in adults with type I Gaucher disease
Long-term therapy with the imiglucerase biosimilar was associated with a stable course of GD without progression. It was characterized by a good safety profile and low immunogenicity.
Authors
- Rais K. Khayretdinov (ORCID: https://orcid.org/0000-0002-7983-642X)
- Vadim Bezrukikh (ORCID: https://orcid.org/0000-0002-2710-2686)
- Е. В. Сайфуллина (ORCID: https://orcid.org/0000-0001-9552-8948)
- О. А. Markova (ORCID: https://orcid.org/0000-0002-1179-3881)
- Elena Lukina (ORCID: https://orcid.org/0000-0002-8774-850X)
- С. А. Волкова (ORCID: https://orcid.org/0000-0002-6476-7281)
- Evgeniy V. Vasiliev (ORCID: https://orcid.org/0000-0003-3780-3758)
- Tatiana Shelekhova
- A.Yu. Borozinets (ORCID: https://orcid.org/0000-0002-4863-8471)
- Е. Г. Кириллова (ORCID: https://orcid.org/0009-0009-1015-4226)
- О. Е. Данилова (ORCID: https://orcid.org/0000-0002-4322-0447)
- Marina Kosinova (ORCID: https://orcid.org/0000-0001-9181-6184)
- Р. В. Пономарев (ORCID: https://orcid.org/0000-0002-1218-0796)
- И. Л. Давыдкин (ORCID: https://orcid.org/0000-0002-4318-4247)
- E. V. Zuev (ORCID: https://orcid.org/0000-0001-5519-8358)
- Galina N. Salogub (ORCID: https://orcid.org/0000-0001-8951-1680)
Institutions
- Privolzhsky Research Medical University (RU)
- Federal Almazov North-West Medical Research Centre (RU)
- Medical Genetics Center (DE)
- Saratov State Medical University (RU)
- Bashkir State Medical University (RU)
- Krasnoyarsk Regional Clinical Hospital (RU)
- Samara State Medical University (RU)
Publication Details
- Journal
- Terapevticheskii arkhiv
- Published
- 2025-03-26
- DOI
- https://doi.org/10.26442/00403660.2025.02.203194
- Citations
- 1
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 1.16